EXOC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.406000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.787040E-01
Normal-vs-Stage2
2.295500E-02
Normal-vs-Stage3
5.279600E-02
Normal-vs-Stage4
2.206200E-01
Stage1-vs-Stage2
4.135000E-01
Stage1-vs-Stage3
1.702780E-01
Stage1-vs-Stage4
9.425800E-01
Stage2-vs-Stage3
3.640200E-01
Stage2-vs-Stage4
5.547000E-01
Stage3-vs-Stage4
2.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.748100E-02
Normal-vs-AfricanAmerican
3.103400E-01
Normal-vs-Asian
1.096060E-02
Caucasian-vs-AfricanAmerican
2.578200E-01
Caucasian-vs-Asian
1.814810E-01
AfricanAmerican-vs-Asian
5.209800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.088100E-02
Normal-vs-Female
3.486500E-02
Male-vs-Female
7.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.781760E-01
Normal-vs-Age(41-60Yrs)
9.169600E-02
Normal-vs-Age(61-80Yrs)
2.234500E-02
Normal-vs-Age(81-100Yrs)
9.896300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.645800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.422600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.463400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.933900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.814000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.029670E-02
Normal-vs-Daily Drinker
1.092230E-02
Normal-vs-Weekly Drinker
3.588400E-02
Normal-vs-Occasional Drinker
1.693240E-01
Normal-vs-Social Drinker
1.439200E-01
Non Drinker-vs-Daily Drinker
7.203600E-01
Non Drinker-vs-Weekly Drinker
6.344400E-01
Non Drinker-vs-Occasional Drinker
2.272000E-01
Non Drinker-vs-Social Drinker
1.928230E-01
Daily Drinker-vs-Weekly Drinker
4.632400E-01
Daily Drinker-vs-Occasional Drinker
1.762170E-01
Daily Drinker-vs-Social Drinker
1.452360E-01
Weekly Drinker-vs-Occasional Drinker
5.428800E-01
Weekly Drinker-vs-Social Drinker
4.816200E-01
Occasional Drinker-vs-Social Drinker
9.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.109840E-01
Normal-vs-Grade 2
5.081900E-02
Normal-vs-Grade 3
5.064400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.997600E-01
Grade 1-vs-Grade 3
6.528800E-01
Grade 1-vs-Grade 4
1.109840E-01
Grade 2-vs-Grade 3
8.435600E-01
Grade 2-vs-Grade 4
5.081900E-02
Grade 3-vs-Grade 4
5.064400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.005900E-02
Normal-vs-NonDiabetic
1.588300E-02
Diabetic-vs-NonDiabetic
7.559800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.055000E-03
Normal-vs-NoPancreatitis
2.903600E-02
Pancreatitis-vs-NoPancreatitis
6.236000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.844000E-02
Normal-vs-N1
2.133700E-02
N0-vs-N1
1.614050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.684030E-02
Normal-vs-TP53-NonMutant
2.176400E-01
TP53-Mutant-vs-TP53-NonMutant
2.738200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
